Search Results

Zynex, Inc. introduced two new therapy products: the Zynex Pro Hybrid LSO and the Zynex DynaComp Cold Compression.

February 20, 2024

·

1 min read

Zynex to Present at the RBC Capital Markets Global Healthcare Conference

Zynex, Inc. announced it will present at the upcoming RBC Capital Markets Global Healthcare Conference, which is being held May 14-15, 2024.

May 9, 2024

·

1 min read

BioMidwest

Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024

Zynex, Inc. announced that it will participate in an analyst-led fireside chat on an RBC Capital Markets 2024 Medical Device Strategy & Innovation Call at 11:00 AM ET on Thursday, June 13, 2024.

June 10, 2024

·

1 min read

Business

Zynex Sets First Quarter 2024 Earnings Call

Zynex, Inc. will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024.

April 18, 2024

·

1 min read

Business

Zynex Reports First Quarter 2024 Financial Results

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the first quarter ended March 31, 2024.

April 30, 2024

·

12 min read

Business

Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award

Zynex, Inc. today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY.

April 2, 2024

·

2 min read

BioMidwest

Zynex Recognized in Top 25 Medical Device Companies for 2024

Zynex, Inc. announced The Healthcare Technology Report recognized Zynex as 9th amongst the Top 25 Medical Device Companies for 2024.

February 2, 2024

·

1 min read

Zynex to Participate at the Needham Annual Growth Conference

Zynex, Inc. announced it will participate virtually in the upcoming Needham Annual Growth Conference, which is being held January 16th-19th, 2024.

January 8, 2024

·

1 min read

Business

Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call

Zynex, Inc. will hold a conference call on Thursday, February 29, 2024 at 4:15 PM Eastern Time to discuss its financial results for the fourth quarter and full year ended December 31, 2023.

February 22, 2024

·

1 min read

FDA

Zynex Receives FDA Clearance for its Next Generation NMES Device

Zynex, Inc today announced that it has received clearance from the U.S. Food and Drug Administration (“FDA”) for the next generation M-Wave Neuromuscular Electrical Stimulation (“NMES”) device.

February 6, 2024

·

4 min read